LABORATORY CRP OF AMER HLDGS (LH)
US50540R4092 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 99.30M | 536.80M | 430.00M | 1.47B | 1.32B | |||
| Receivables | 2.20B | 2.10B | 3.02B | 2.98B | 3.02B | |||
| Inventories | 475.00M | 474.60M | 471.00M | 401.00M | 423.00M | |||
| Other Current Assets | 678.10M | 655.30M | 707.00M | 478.00M | 365.00M | |||
| Total Current Assets | 3.46B | 3.77B | 4.63B | 5.33B | 5.13B | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.90B | 2.98B | 3.03B | 2.90B | 2.81B | |||
| Investments And Advances | 17.70M | 26.90M | 66.00M | 61.00M | 74.00M | |||
| Goodwill | 6.22B | 6.14B | 8.12B | 7.96B | 7.75B | |||
| Intangibles | 3.39B | 3.34B | 3.95B | 3.74B | 3.96B | |||
| Other Non-Current Assets | 546.00M | 467.00M | 365.00M | 403.00M | 351.00M | |||
| Total Non-Current Assets | 13.07B | 12.96B | 15.53B | 15.05B | 14.95B | |||
| TOTAL ASSETS | 16.53B | 16.73B | 20.16B | 20.39B | 20.07B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.05B | 1.01B | 307.00M | 12.00M | 383.00M | |||
| Accrued Expenses | 820.60M | 842.30M | 1.11B | 1.35B | 1.18B | |||
| Accounts Payable | 695.50M | 827.50M | 935.00M | 621.00M | 639.00M | |||
| Other Current Liabilities | 377.50M | 549.20M | 728.00M | 798.00M | 881.00M | |||
| Total Current Liabilities | 3.94B | 3.23B | 3.08B | 2.78B | 3.08B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.12B | 4.13B | 5.12B | 5.50B | 5.50B | |||
| Deferred Taxes/Income | 397.20M | 417.90M | 736.00M | 763.00M | 905.00M | |||
| Other Non-Current Liabilities | 1.09B | 1.06B | 1.10B | 1.04B | 1.20B | |||
| Total Non-Current Liabilities | 4.63B | 5.62B | 6.98B | 7.33B | 7.63B | |||
| TOTAL LIABILITIES | 8.57B | 8.85B | 10.06B | 10.11B | 10.71B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 8.06B | 7.89B | 10.58B | 10.46B | 9.40B | |||
| Additional Paid In Capital | 82.00M | 38.40M | N/A | 0.00 | 110.00M | |||
| Minority Interest | 14.90M | 14.30M | 17.00M | 19.00M | 20.00M | |||
| Common Shares | 7.70M | 7.70M | 8.00M | 9.00M | 9.00M | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -185.40M | -59.30M | -493.00M | -192.00M | -162.00M | |||
| Shares Outstanding | 84.30M | 83.90M | 88.00M | 93.00M | 98.00M | |||
| Tangible Book Value per Share | -19.61 | -19.18 | -22.40 | -15.29 | -24.01 | |||
| Total Shareholders' Equity | 7.96B | 7.88B | 10.10B | 10.27B | 9.36B | |||
| TOTAL LIABILITIES AND EQUITY | 16.53B | 16.73B | 20.16B | 20.39B | 20.07B | |||
| Statistics | ||||||||
| Debt/Equity | 0.39 | 0.52 | 0.51 | 0.54 | 0.59 | |||
| Current Ratio | 0.88 | 1.17 | 1.50 | 1.92 | 1.66 | |||
| Return On Assets (ROA) | 2.62% | 2.50% | 6.35% | 11.66% | 7.75% | |||
| Return On Equity (ROE) | 5.44% | 5.31% | 12.67% | 23.14% | 16.62% | |||
| Return On Invested Capital (ROIC) | 6.53% | 6.15% | 9.21% | 14.09% | 13.06% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 6.58% | 6.41% | 9.45% | 15.38% | 14.16% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 28.58% | 23.87% | 34.36% | 55.93% | 56.05% | |||
All data in USD